B4

General Information


DRACP ID  DRACP00589

Peptide Name   B4

Sequence  IRKLKSWKWLRWL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma Not active up to 170 µM Trypan Blue exclusion assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00589

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C90H141N25O15

Absent amino acids  ACDEFGHMNPQTVY

Common amino acids  KLW

Mass  202749

Pl  12.55

Basic residues  5

Acidic residues  0

Hydrophobic residues  7

Net charge  5

Boman Index  -2322

Hydrophobicity  -63.85

Aliphatic Index  120

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  16500

Absorbance 280nm  1375

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26902758

Title  Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis

Doi 10.1128/AAC.00940-15

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.